The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | Genomic profiling SMM
Mark Bustoros
• 13 Sep 2019
Mark Bustoros, MD, Dana-Farber Cancer Institute, Boston, MA, interviews with VJHemOnc at the International Myeloma Workshop (IMW) 2019, held in Boston, MA, and discusses how the genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression.
